How Staff Augmentation Assists with Successful Data Migration
Staff Augmentation aids data migration by assessing workflows, ensuring a smooth transition to OnCore, and empowering teams with tailored training.
Staff Augmentation aids data migration by assessing workflows, ensuring a smooth transition to OnCore, and empowering teams with tailored training.
Learn how UChicago Comprehensive Cancer Center streamlined research administration with Advarra EVAL, improving data management and reporting.
Learn how the University of Kentucky Markey Cancer Center utilized OnCore to streamline processes and achieve prestigious NCI designation.
Discover how Atrium Health’s OnCore-EMR integration ensures trial status visibility, improving treatment quality for patients and trial subjects.
Compliant document storage in clinical trials demands robust systems for security, accessibility, and retention to meet privacy and regulatory standards.
Wayne State University simplifies FDA trial compliance by integrating Advarra EDC and Validation Services, reducing reliance on external vendors.
Advarra’s Study Startup solution provided training for every staff member at every global trial site, inclusive of real-time training reports, helping to ensure all 20,000 patients enrolled were treated exactly according to protocol, and enrolled seven months ahead of target
In a recent webinar, James Riddle, Shannon Roznoski, and Stuart Cotter of Advarra presented Regulatory Fine Points: Exploring 21 CFR Part
The processes necessary to support regulatory compliance require valuable time and resources within a clinical research institution. Regulatory tasks in particular require frequent
Learn how Inova Health System achieved a 20% increase in regulatory efficiency through Advarra eReg, optimizing operations without extra staff.
It’s safe to say 2020 has been more unpredictable than anyone could imagine. Through these unprecedented times, we have worked to provide the
Top 20 Biopharma Doubles Recruitment and Reduces Screen Failures Across 188 Sites A top-20 pharmaceutical company conducted a complex Phase